Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model
PubMed PMID: 24434211
1 μM for both GNE-7915 (100-fold over LRRK2 Ki) and 19 (250-fold over LRRK2 Ki) resultes in only TTK showing greater than 50% inhibition
Smiles: [2H]C1=C(C(=O)N[C@H]([C@@H](O)C(=O)O[C@H]2C[C@@]3(O)[C@@H](OC(=O)C4C=CC=CC=4)[C@@H]4[C@@]5(CO[C@@H]5C[C@H](O)[C@@]4(C)C(=O)[C@H](OC(C)=O)C(=C2C)C3(C)C)OC(C)=O)C2C=CC=CC=2)C([2H])=C([2H])C([2H])=C1[2H]
Piromidic acid 16253 Nrf2 activators attenuate the progressionPiromidic acid is an antibacterial agent. Piromidic acid is active against gramnegative bacteria and staphylococci and can be used for the research of intestinal, urinary, and biliary tract infections. Product information CAS Number: 19562 30 2 Molecular Weight: 288. 30 Formula: C14H16N4O3 Chemical Name: 8 ethyl 5 oxo 2 (pyrrolidin 1 yl) 5H,8H pyrido[2,3 d]pyrimidine 6 carboxylic acid Smiles: CCN1C=C(C(O)=O)C(=O)C2=CN=C(N=C12)N1CCCC1 InChiKey:
US$ 2656.50
US$ 1426.00
US$ 1997.00
US$ 1002.00